OsteoCool RF Ablation System approved by FDA to treat pain from spine metastases- Medtronic

The FDA has given 510(k) clearance of the OsteoCool RF Ablation System, from Medtronic, to treat patients with painful spine metastases using targeted high-frequency energy. The OsteoCool System is the only cooled radiofrequency (RF) ablation technology that offers simultaneous, dual-probe capabilities, providing procedural flexibility and customised treatment. The device is currently pending CE marking.

The system uses internally water-cooled probes to prevent overheating of surrounding tissue during the procedure. The 17-gauge, bipolar probes are available in three lengths and may be used through a variety of cannula sizes. Because two OsteoCool RF ablation probes can be used simultaneously, the system supports a variety of ablation scenarios accommodating unique patient and procedural needs.